These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8529061)

  • 1. Effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients.
    Watanabe T; Noshiro T; Akama H; Kusakari T; Shibukawa S; Miura W; Abe K; Miura Y
    Hypertens Res; 1995 Jun; 18 Suppl 1():S197-8. PubMed ID: 8529061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma free dopamine: physiological variability and pathophysiological significance.
    Miura Y; Watanabe T; Noshiro T; Shimizu K; Kusakari T; Akama H; Shibukawa S; Miura W; Ohzeki T; Takahashi M
    Hypertens Res; 1995 Jun; 18 Suppl 1():S65-72. PubMed ID: 8529077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of high sodium diet on dopaminergic mechanism in normal and hypertensive subjects].
    Takahashi M; Miura Y; Sano N; Ohzeki T; Sugawara T; Noshiro T; Meguro Y; Watanabe H; Shimizu K; Hanew K
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov; 64(11):1157-68. PubMed ID: 3065095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma catecholamine responses to tyrosine hydroxylase inhibition and cold exposure.
    Avakian EV; Horvath SM
    Life Sci; 1980 May; 26(20):1691-6. PubMed ID: 6104766
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension.
    Snider SR; Kuchel O
    Endocr Rev; 1983; 4(3):291-309. PubMed ID: 6354703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sympathetic nervous system in essential hypertension.
    Tuck ML
    Am Heart J; 1986 Oct; 112(4):877-86. PubMed ID: 3532745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial changes in noradrenergic and dopaminergic activity in patients with essential hypertension.
    Ishii H; Shigetomi S; Niimura S; Sanada H; Fukuchi S
    Hypertens Res; 1995 Jun; 18 Suppl 1():S199-200. PubMed ID: 8529062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma norepinephrine and epinephrine levels in essential hypertension.
    Goldstein DS; Lake CR
    Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine surges in hyperadrenergic essential hypertension.
    Kuchel O; Buu NT; Hamet P; Larochelle P; Bourque M; Genest J
    Hypertension; 1982; 4(6):845-52. PubMed ID: 7141610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tyrosine hydroxylase up regulation in dexamethasone-induced hypertension of rats.
    Kumai T; Asoh K; Tateishi T; Tanaka M; Watanabe M; Shimizu H; Kobayashi S
    Life Sci; 2000 Sep; 67(16):1993-9. PubMed ID: 11072875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
    Kuchel O
    Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of dopamine involvement in essential hypertension.
    Kuchel O
    Clin Exp Hypertens A; 1989; 11 Suppl 1():217-25. PubMed ID: 2663248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
    Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
    Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional sources of free and sulfoconjugated catecholamines in hypertension.
    Kuchel O; Buu NT; Roy P; Hamet P; Larochelle P; Genest J
    Hypertension; 1984; 6(2 Pt 2):I51-5. PubMed ID: 6547113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR; Mogenson GJ
    Brain Res; 1990 Aug; 524(2):271-81. PubMed ID: 1981327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M; Young SJ; Groves PM
    Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine in the neurotoxic effects of methamphetamine.
    Schmidt CJ; Ritter JK; Sonsalla PK; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):539-44. PubMed ID: 2409267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.